Warning Letter Roundup & Recap –December 22, 2015
This article was originally published in The Gray Sheet
Executive Summary
Device firm Elite Massagers received two complaints – including one that described a user being shocked by an Elite Multi device – yet failed to investigate; Dutch Ophthalmic Research Center cited for premarket violations. Two device warning letters were listed by FDA last week.
You may also be interested in...
RedHill On The Rise With Three Drugs And Potential COVID-19 Therapy
The Israeli biotech which is listed on the NASDAQ is in for a busy 2021 with strong marketing pushes for Movantik, Aemcolo and Talicia and completing a pivotal trial for COVID-19 hopeful opaganib.
Pipeline Watch: Phase III Starts In PAH, NSCLC And Seizure Disorders
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Billionaire Mark Cuban Surprises With US Generics Venture
To increase transparency and affordability, American billionaire and businessman Mark Cuban has launched a US generics venture under the name ‘the Mark Cuban Cost Plus Drugs Company.’ Cuban’s new company is hoping to introduce over 100 drugs by the end of 2021 and build a pharmaceutical factory of its own by 2022.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: